Page 6 THE REVERE ADVOCATE – Friday, January 17, 2020 8 Norwood St. Everett (617) 387-9810 www.eight10barandgrille.com Kitchen Hours: Mon-Thurs: 12-10pm Fri-Sat: 12-11pm Sunday: 1pm-10pm $12 LUNCH Menu! Come in & Enjoy our Famous... Choose from 16 Items! Served Monday thru Thursday until 3:30 PM Grilled Rib Eye Steak! Only $22.00 includes Two Sides Every Friday FRESH HADDOCK DINNER Prepared Your Way! Includes two sides Catch the NFL on our 10 TV’s! Cancer mortality rate in steady decline T he cancer death rate declined by 29 percent from 1991 to 2017, including a 2.2 percent drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported. The news comes from “Cancer statistics, 2020,” the latest edition of the American Cancer Society’s annual report on cancer rates and trends. The article appears online in “CA: A Cancer Journal for Clinicians” and is accompanied by a consumer version, “Cancer Facts & Figures 2020.” The steady 26-year decline in overall cancer mortality is driven by long-term drops in death rates for the four major cancers – lung, colorectal, breast and prostate, although recent trends are mixed. The pace of mortality reductions for lung cancer – the leading cause of cancer death – accelerated in recent years (from two percent per year to four percent overall), spurring the record one-year drop in overall cancer mortality. In contrast, progress slowed for colorectal, breast and prostate cancers. SKATING CENTER www.Roller-World.com | 781-231-1111 ATM on site Sunday Located Adjacent to Rite Aid Pharmacy in Saugus Plaza, South Bound Route 1 MBTA Bus Route 429 FREE WI-FI - 2 WIDE SCREEN TV’S FULLY AIR CONDITIONED WINTER SKATING SCHEDULE ATTENTION! 12-8 p.m. $7.50 Monday Private Parties Tuesday School & PTO GROUPS 7:30-10:30 p.m. Adult Night 18+ only $8.50 Wednesday Private Parties Thursday Private Parties 3-11 p.m. $7.50 Friday Saturday Admission after 6 p.m. $8.50 12-11 p.m. $7.50 Admission after 6 p.m. $8.50 Skates included in price/Blades $3 Bowling Alleys, 2 snack bars, video games. School Vacation Weeks 12-8 p.m. Admission $7.50 Win a trip for 2 to Las Vegas Bellagio Hotel Jet Blue Air 5 days / 4 nights Your school PTO can for your group. Call for details. BIRTHDAY PARTIES $11.50/Person, min. of 10 kids. Price includes Adm. + Roller Skates. Cake, soda, paper goods, 20 tokens for birthday person plus 100 Redemption Tickets and a gift from Roller World in one of our private BP Rooms. Overall cancer death rates dropped by an average of 1.5 percent per year during the most recent decade of data (2008-2017), continuing a trend that began in the early 1990s and resulting in the 29-percent drop in cancer mortality in that time. The drop translates to approximately 2.9 million fewer cancer deaths than would have occurred had mortality rates remained at their peak. Continuing declines in cancer mortality contrast with a stable trend for all other causes of death combined, refl ecting a slowing decline for heart disease, stabilizing rates for cerebrovascular disease and an increasing trend for accidents and Alzheimer’s disease. Lung cancer death rates have dropped by 51 percent (since 1990) in men and by 26 percent (since 2002) in women, with the most rapid progress in recent years. For example, reductions in mortality accelerated from three percent per year during 2008-2013 to fi ve percent per year during 2013-2017 in men, and from two percent to almost four percent in women. However, lung cancer still accounts for almost one-quarter of all cancer deaths, more than breast, prostate and colorectal cancers combined. The most rapid declines in mortality occurred for melanoma of the skin, on the heels of breakthrough treatments approved in 2011 that pushed one-year survival for patients diagnosed with metastatic disease from 42 percent during 2008-2010 to 55 percent during 2013-2015. This progress is likewise refl ected in the overall melanoma death rate, which dropped by seven percent per year during 2013-2017 in people ages 20 to 64, compared to declines during 2006-2010 (prior to FDA approval of ipilimumab and vemurafenib) of two percent to three percent per year in those ages 20 to 49 and one percent per year in those ages 50 to 64. Even more striking are the mortality declines of fi ve percent to six percent in individuals 65 and older, among whom rates were previously increasing. “The news this year is mixed,” said Rebecca Siegel, MPH, coauthor of the report. “The exciting gains in reducing mortality for melanoma and lung cancer are tempered by slowing progress for colorectal, breast, and prostate cancers, which are amenable to early detection. It’s a reminder that increasing our investment in the equitable application of existing cancer control interventions, as well as basic and clinical research to further advance treatment, would undoubtedly accelerate progress against cancer.” Highlights from the report include: • The death rate for breast cancer dropped by 40 percent from 1989 to 2017. • The death rate for prostate cancer dropped by 52 percent from 1993 to 2017. • The death rate for colorectal cancer dropped by 53 percent from 1980 to 2017 among males and by 57 percent from 1969 to 2017 among females. • Decades-long rapid increases in liver cancer mortality appear to be abating in both men and women. • Cervical cancer, which is almost completely preventable, caused 10 premature deaths per week in women ages 20-39 in 2017. Other highlights include: • In 2020, 1,806,590 new cancer cases and 606,520 cancer deaths are projected to occur in the United States. • Progress for hematopoietic and lymphoid malignancies (leukemias and lymphomas) has been especially rapid due to improvements in treatment protocols, including the development of targeted therapies. The five-year relative survival rate for chronic myeloid leukemia increased from 22 percent in the mid-1970s to 70 percent for those diagnosed during 2009 through 2015, and most patients treated with tyrosine kinase inhibitors now experience nearly normal life expectancy. Overall, the cancer incidence rate in men declined rapidly from 2007 to 2014, but stabilized through 2016, refl ecting slowing declines for colorectal cancer and stabilizing rates for prostate cancer. The overall cancer incidence rate in women has remained generally stable over the past few decades because lung cancer declines have been off set by a tapering decline for colorectal cancer and increasing or stable rates for other common cancers in women. The slight rise in breast cancer incidence rates (by approximately 0.3 percent per year) since 2004 has been attributed at least in part to continued declines in the fertility rate and increased obesity, factors that may also contribute to increasing incidence for uterine cancer (1.3 percent per year from 2007-2016). CANCER | SEE PAGE 7
7 Publizr Home